real-time PCR
Qiagen Settles Becton Dickinson Patent Infringement Lawsuit for $53M
BD filed the suit against NeuMoDx, now part of Qiagen, in 2019 for infringing patents related to the use of microfluidic cartridges for molecular diagnostics.
The Rehovot, Israel-based firm expects to soon receive marketing clearance from the US Food and Drug Administration for its methylation-based Bladder EpiCheck test.
While the human toll of the disease has been terrible, IVD makers also report there have been some positive developments, as demand has spiked and familiarity with testing has grown.
Diagenode already sells more than 30 real-time PCR tests that are CE-marked for the detection of bacteria, parasites, and viruses for multiple infectious diseases.
Bio-Rad Q4 Revenues Jump 27 Percent; Firm Gets FDA EUA for COVID/Flu Combo Test
The firm's quarterly revenues beat estimates. Its full year revenues also beat estimates and were up 10 percent year over year.